First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Recruiting

Phase 1

First in Human Study of TORL-2-307-ADC in Participants With Advanced CancerFirst in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Sponsor:

TORL Biotherapeutics, LLC

Code:

NCT05156866

Conditions

Advanced Solid Tumor

Gastric Cancer

Pancreas Cancer

Gastroesophageal Junction Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TORL-2-307-ADC

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by TORL Biotherapeutics, LLC on 2024-10-22.